Kristina Burow, Director, 10% Owner at Neumora Therapeutics, Inc. (NMRA), bought 83,008 shares at $12.31 ($1.0M) on 2023-09-27, disclosed to the SEC on 2023-09-27.
Open-market purchase of $1.0M NMRA by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.73 | 34,000 | $399K | 39.8% |
| 2 | $12.31 | 24,504 | $302K | 30.1% |
| 3 | $12.31 | 24,504 | $302K | 30.1% |
| Total | $12.07 avg | 83,008 | $1.0M | 100% |
| Filing → |
| SRRK | SELL | 2025-05-30 | $160K | — | Filing → |
| MTSR | BUY | 2025-02-03 | $40.0M | — | Filing → |
| BOLD | BUY | 2024-04-04 | $3.2M | — | Filing → |